TFA
TNYA icon

Toth Financial Advisory’s Tenaya Therapeutics TNYA Stock Holding History

Toth Financial Advisory’s Portfolio TNYA Stock Details TNYA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.11K Hold
1,500
– – ﹤0.01% 819
2026
Q1 		$1.04K Buy
+1,500
New +$1.11K ﹤0.01% 809

Other funds holding TNYA

MCP
Mirador Capital Partners Pleasanton, California $817M AUM 42.46% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
EL
EWA LLC Pittsbugh, Pennsylvania $548M AUM 35.14% 1-Year Est. Return
AWM
Avior Wealth Management Omaha, Nebraska $3.8B AUM 23.28% 1-Year Est. Return
SFA
Sequoia Financial Advisors Akron, Ohio $20.1B AUM 24.77% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
VWM
Vermillion Wealth Management Rosemount, Minnesota $427M AUM 12.63% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return

Toth Financial Advisory's TNYA Position: Q2 2026 in Review

Toth Financial Advisory held its Tenaya Therapeutics (TNYA) position steady in Q2 2026 at 1,500 shares worth $1.11K. The position accounts for ﹤0.01% of the portfolio, ranked #819.

Toth Financial Advisory first reported a position in TNYA in Q1 2026 and has held it in 2 quarters since. 9 funds tracked by Wall St. Rank hold TNYA as of Q2 2026.

  • Toth Financial Advisory held 1,500 shares of Tenaya Therapeutics worth $1.11K as of Q2 2026.
  • Toth Financial Advisory left its Tenaya Therapeutics share count unchanged in Q2 2026.
  • Tenaya Therapeutics made up ﹤0.01% of Toth Financial Advisory's portfolio in Q2 2026, its #819 holding.
  • Toth Financial Advisory first reported a position in Tenaya Therapeutics in Q1 2026 and has held it in 2 quarters since.
  • 9 funds tracked by Wall St. Rank held Tenaya Therapeutics as of Q2 2026.

Based on Toth Financial Advisory's 13F filing for Q2 2026, filed 14 Jul 2026.